Ozempic doesn’t actually have a weight requirement because it’s not approved for weight loss. It’s an FDA-approved treatment for type 2 diabetes, so the qualifying factor is your blood sugar, not your BMI. If you’re looking for a semaglutide prescription specifically to lose weight, the drug you’re thinking of is Wegovy, which contains the same active ingredient at a higher dose and does have specific BMI thresholds.
That distinction matters because it changes what your doctor will evaluate, what insurance will cover, and what you need to qualify.
Why Ozempic Has No BMI Requirement
The FDA approved Ozempic for three specific purposes: improving blood sugar control in adults with type 2 diabetes, reducing the risk of heart attack and stroke in adults with type 2 diabetes and established cardiovascular disease, and protecting kidney function in adults with type 2 diabetes and chronic kidney disease. None of these indications mention body weight or BMI.
In practice, many people prescribed Ozempic for diabetes do lose weight as a side effect, and some doctors prescribe it off-label for weight management. But officially, the prescription hinges on having type 2 diabetes, typically confirmed by an A1C blood test showing your blood sugar is not well controlled with other treatments. Your doctor will also consider whether you have heart disease, kidney disease, or heart failure, all of which are covered indications.
BMI Thresholds for Wegovy
Wegovy is the version of semaglutide designed and dosed for weight management. To qualify, you need to meet one of two criteria: a BMI of 30 or higher (which falls in the obesity range), or a BMI of 27 or higher combined with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol.
To put those numbers in context, the CDC classifies adult BMI categories like this:
- Overweight: BMI 25 to 29.9
- Class 1 obesity: BMI 30 to 34.9
- Class 2 obesity: BMI 35 to 39.9
- Class 3 (severe) obesity: BMI 40 or higher
So if your BMI is between 27 and 30, you’d need a documented condition like high blood pressure or high cholesterol to qualify for Wegovy. At a BMI of 30 or above, the weight alone is sufficient for the prescription.
What Insurance Actually Requires
Meeting the FDA criteria doesn’t guarantee your insurance will cover the medication. Many insurers require prior authorization, which means your doctor has to submit documentation proving you qualify. The specific requirements vary widely by plan and by state.
Some state Medicaid programs don’t cover GLP-1 medications for weight loss at all, only for diabetes and other approved diagnoses. Pennsylvania’s Medicaid program, for example, explicitly excludes coverage of GLP-1 drugs for overweight and obesity, while covering them for diabetes, cardiovascular risk reduction, sleep apnea, and liver disease. For cardiovascular risk reduction specifically, that program requires a BMI of at least 27 plus documented history of heart attack, stroke, or peripheral artery disease. For sleep apnea, the threshold jumps to a BMI of 35 or higher with confirmed moderate-to-severe sleep apnea.
Private insurance plans set their own rules, but many require documentation that you’ve tried diet and exercise or other interventions before they’ll approve a GLP-1 prescription. Without coverage, the out-of-pocket cost for these medications can run over $1,000 per month.
How Much Weight Semaglutide Typically Produces
Clinical trials give a useful benchmark for what to expect. In the STEP 4 trial published in JAMA, participants lost an average of 10.6% of their body weight during a 20-week initial treatment period with semaglutide. Those who continued treatment for another 48 weeks lost an additional 7.9% on average, while those switched to a placebo regained weight. For someone starting at 250 pounds, a 10.6% loss translates to roughly 26 pounds in the first five months.
These results came from trial participants using the higher Wegovy dose of semaglutide (2.4 mg weekly) rather than the typical Ozempic doses used for diabetes (up to 2 mg weekly). Weight loss on Ozempic prescribed for diabetes tends to be lower, though still meaningful for many people.
Tests Your Doctor Will Run First
Before prescribing any form of semaglutide, your doctor will typically order bloodwork to establish a baseline and check for conditions that could make the drug risky. Standard pre-treatment screening includes A1C and fasting blood sugar (to confirm diabetes status or catch undiagnosed diabetes), kidney function tests, thyroid hormone levels, liver enzymes, and cholesterol panels.
Pancreatic enzyme levels (lipase and amylase) are also recommended, since semaglutide carries a small risk of pancreatitis. Your doctor should ask about your personal and family history of thyroid cancer, particularly a rare type called medullary thyroid carcinoma. The FDA has placed a boxed warning on semaglutide based on animal studies showing a risk of thyroid tumors, so a personal or family history of this cancer is a disqualifying factor regardless of your weight or diabetes status.
If You Want Semaglutide for Weight Loss
If your goal is weight loss rather than blood sugar control, ask your doctor specifically about Wegovy. Both drugs contain semaglutide and work the same way, reducing appetite by mimicking a gut hormone that signals fullness to the brain. The difference is purely regulatory: Wegovy is approved for weight management at higher doses, and Ozempic is approved for type 2 diabetes.
Some doctors do prescribe Ozempic off-label for weight loss, particularly when Wegovy is unavailable or when insurance won’t cover Wegovy but will cover Ozempic with a diabetes diagnosis. This is a conversation to have openly with your provider, since off-label use affects what your insurance will pay and what dose you’ll receive. Being straightforward about your goals helps your doctor match you with the right medication and navigate the approval process more effectively.